SCHEMBL2977498

SCHEMBL2977498

Cc1cccc2c(=O)c(C(=O)O)c[nH]c12

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.67
▸ ALDH1A1 P00352 2/20 0.67
▸ HPGD P15428 2/20 0.67
▸ BRPF1 P55201 1/20 0.64
▸ CSNK2A2 P19784 3/20 0.63
▸ CSNK2B P67870 3/20 0.63
▸ CSNK2A1 P68400 3/20 0.63
▸ TSHR P16473 1/20 0.63
▸ HTT P42858 1/20 0.63
▸ NPSR1 Q6W5P4 1/20 0.63
▸ POLB P06746 1/20 0.62
▸ RAB9A P51151 1/20 0.62
▸ DNA2 P51530 1/20 0.61
▸ CASP6 P55212 1/20 0.61
▸ CTDSP1 Q9GZU7 1/20 0.61
▸ NR4A2 P43354 1/20 0.59
▸ CYP1A2 P05177 1/20 0.55
▸ HSD17B10 Q99714 1/20 0.55
▸ CLEC4M Q9H2X3 1/20 0.54
▸ TET2 Q6N021 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28606562 0.98 KDM4E (0.65) KDM4EALDH1A1HPGDBRPF1CSNK2A2
SCHEMBL3978031 0.90 BRPF1 (0.77) KDM4EALDH1A1HPGDBRPF1CSNK2A2
SCHEMBL29950385 0.86 BRPF1 (0.62) KDM4EALDH1A1HPGDBRPF1CSNK2A2
SCHEMBL28287757 0.85 RAB9A (0.60) KDM4EALDH1A1HPGDBRPF1CSNK2A2
SCHEMBL18589537 0.85 CSNK2A2 (0.69) KDM4EALDH1A1HPGDCSNK2A2CSNK2B
SCHEMBL28287764 0.83 BRPF1 (0.59) KDM4EALDH1A1HPGDBRPF1CSNK2A2
SCHEMBL1244916 0.82 CSNK2A2 (0.65) KDM4EALDH1A1HPGDCSNK2A2CSNK2B
SCHEMBL9653780 0.82 BRPF1 (0.57) KDM4EALDH1A1HPGDBRPF1TSHR
SCHEMBL2977296 0.81 TSHR (0.64) KDM4EALDH1A1HPGDCSNK2A2CSNK2B
SCHEMBL28287748 0.81 ALDH1A1 (0.60) KDM4EALDH1A1HPGDBRPF1CSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514451-B2 7-(4-Substituted-3-cyclopropylaminomethyl-1 pyrrolidinyl) quinolonecarboxylic acid derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2009-04-07 — — US claimed
US-12377079-B2 Antibacterial compounds and uses thereof THE CHILDREN'S MEDICAL CENTER CORPORATION 2025-08-05 — — US disclosed
CN-113185505-B Quinolone oxazolidinone compound and preparation method and application thereof 中国农业大学 2022-09-27 — — CN disclosed
US-20220023270-A1 ANTIBACTERIAL COMPOUNDS AND USES THEREOF THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 2022-01-27 — — US disclosed
CN-113185505-A Quinolone oxazolidinone compound and preparation method and application thereof 中国农业大学 2021-07-30 — — CN disclosed
US-20170066722-A1 AGENTS FOR USE IN THE TREATMENT OF CARDIOVASCULAR AND INFLAMMATORY DISEASES STRUCTURALLY BASED ON 4(1 H)-QUINOLONE UCL BUSINESS PLC (GB) 2017-03-09 — — US disclosed
US-20170066722-A1 AGENTS FOR USE IN THE TREATMENT OF CARDIOVASCULAR AND INFLAMMATORY DISEASES STRUCTURALLY BASED ON 4(1 H)-QUINOLONE UCL BUSINESS PLC (GB) 2017-03-09 — — US disclosed
US-20140343098-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-11-20 — — US disclosed
US-8802700-B2 Modulators of ATP-Binding Cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-08-12 — — US disclosed
US-8614327-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-12-24 — — US disclosed
US-20130165442-A1 Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-06-27 — — US disclosed
US-8354427-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICAL INCORPORATED (US) 2013-01-15 — — US disclosed
US-20120309758-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-12-06 — — US disclosed
EP-1857453-B1 FLUOROALKYLPYRROLIDINE DERIVATIVES DAIICHI SANKYO CO LTD (JP) 2010-12-29 — — EP disclosed
US-20100184739-A1 Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-07-22 — — US disclosed
US-20090012119-A1 FLUOROALKYLPYRROLIDINE DERIVATIVE DAIICHI SANKYO COMPANY LIMITED (JP) 2009-01-08 — — US disclosed
EP-1857453-A1 FLUOROALKYLPYRROLIDINE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2007-11-21 — — EP disclosed
US-20020193591-A1 Process for producing 5-amino-8-alkylquinolonecarboxylic acid derivative and intermediates in the production thereof DAIICHI PHARMACEUTICAL CO., LTD. 2002-12-19 — — US disclosed
EP-1167344-A1 PROCESS FOR PRODUCING 5-AMINO-8- ALKYLQUINOLO NECARBOXYLIC ACID DERIVATIVES AND INTERMEDIATES IN THE PRODUCTION THEREOF DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2002-01-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165442-A1 Modulators of ATP-Binding Cassette Transporters CFTR, ABCB1, ABCC2 KDM4E 4262/4885ALDH1A1 2165/4885HPGD 1121/4885
US-20020193591-A1 Process for producing 5-amino-8-alkylquinolonecarboxylic acid derivative and intermediates in the production thereof SQOR, XDH, SPOUT1 KDM4E 991/4885ALDH1A1 1145/4885HPGD 404/4885
US-20100184739-A1 Modulators of ATP-Binding Cassette Transporters CFTR, ABCB1, ABCC2 KDM4E 4262/4885ALDH1A1 2165/4885HPGD 1121/4885
US-20140343098-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 KDM4E 4262/4885ALDH1A1 2165/4885HPGD 1121/4885
US-20170066722-A1 AGENTS FOR USE IN THE TREATMENT OF CARDIOVASCULAR AND INFLAMMATORY DISEASES STRUCTURALLY BASED ON 4(1 H)-QUINOLONE CBR3, AGTR1, CBR1 KDM4E 4288/4885ALDH1A1 3209/4885HPGD 1392/4885
US-12377079-B2 Antibacterial compounds and uses thereof CLPP, SPOUT1, MRPL21 KDM4E 4451/4885ALDH1A1 2700/4885HPGD 1354/4885
US-20220023270-A1 ANTIBACTERIAL COMPOUNDS AND USES THEREOF CLPP, SPOUT1, MRPL21 KDM4E 4451/4885ALDH1A1 2700/4885HPGD 1354/4885
US-20120309758-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 KDM4E 4262/4885ALDH1A1 2165/4885HPGD 1121/4885
US-20090012119-A1 FLUOROALKYLPYRROLIDINE DERIVATIVE FPR1, VIP, Q6ZSR9 KDM4E 2389/4885ALDH1A1 2123/4885HPGD 2256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback